CAN2109

· Canwell Biotech Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAN2109, covering 2024-12-19 to 2024-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Intratumoral CAN2109 in Subjects With Solid Tumors [Phase 1]